Journal ArticleAME Medical Journal · March 30, 2025
Background: Pneumocystis jirovecii pneumonia (PJP) causes significant morbidity and mortality in immunocompromised patients. Current therapeutic options for PJP may be limited by toxicities, and alternate therapeutic options with fewer side effects are lim ...
Full textCite
Journal ArticleClin Infect Dis · October 15, 2024
BACKGROUND: Infectious diseases (ID) physicians are increasingly faced with the challenge of caring for patients with terminal illnesses or incurable infections. METHODS: This was a retrospective cohort of all patients with an ID consult within an academic ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · June 12, 2024
We identified 23 cases of Mycobacterium immunogenum respiratory acquisition linked to a colonized plumbing system at a new hospital addition. We conducted a genomic and epidemiologic investigation to assess for clonal acquisition of M. immunogenum from hos ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · October 5, 2023
BACKGROUND: Rifampin-resistant tuberculosis is a leading cause of morbidity worldwide; only one-third of persons start treatment, and outcomes are often inadequate. Several trials demonstrate 90% efficacy using an all-oral, 6-month regimen of bedaquiline, ...
Full textLink to itemCite
Journal ArticleAnn Am Thorac Soc · September 2023
Rationale: Detection of latent tuberculosis infection (LTBI) in persons born in high tuberculosis (TB) incidence countries living in low TB incidence countries is key to TB elimination in low-incidence countries. Optimizing LTBI tests is critical to target ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · September 2023
BACKGROUND: The 2022 mpox outbreak disproportionately affected men who have sex with men and persons living with HIV (PLWH). A 2-dose mpox vaccine series was deployed in mid-2022. Structural racism and insurance status may have affected equitable vaccinati ...
Full textLink to itemCite
Journal ArticleJ Pediatric Infect Dis Soc · August 31, 2023
While interferon-gamma release assays (IGRAs) are widely used for detecting tuberculosis (TB) infection, tuberculin skin tests (TSTs) remain preferred for children under the age of 2 years. The preference for TST stems from concern over IGRA sensitivity in ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · August 2023
Coinfection with sexually transmitted infections (STIs) and mpox is common. We evaluated concurrent STI testing among Duke Health patients tested for mpox. We found that most patients tested for mpox were not comprehensively tested for STIs, despite concur ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · July 2023
BACKGROUND: We previously identified 3 latent classes of healthcare utilization among people with human immunodeficiency virus (PWH): adherent, nonadherent, and sick. Although membership in the "nonadherent" group was associated with subsequent disengageme ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · April 17, 2023
BACKGROUND: Nontuberculous mycobacteria (NTM) are emerging pathogens increasingly implicated in healthcare facility-associated (HCFA) infections and outbreaks. We analyzed the performance of statistical process control (SPC) methods in detecting HCFA NTM o ...
Full textLink to itemCite
Journal ArticlePLoS One · 2023
OBJECTIVE: Pandemic-associated stress may have exacerbated preexisting mental health and substance use disorders (MH/SUD) and caused new MH/SUD diagnoses which would be expected to lead to an increase in visits to emergency departments and hospital admissi ...
Full textOpen AccessLink to itemCite
Journal ArticleOpen Forum Infect Dis · December 2022
BACKGROUND: US tuberculosis (TB) guidelines recommend treatment ≥6 months with a regimen composed of multiple effective anti-TB drugs. Since 2003, a 4-month regimen for a specific subset of TB patients has also been recommended. METHODS: We used 2011-2018 ...
Full textLink to itemCite
Journal ArticleCell · November 23, 2022
The human pathogen Mycobacterium tuberculosis typically causes lung disease but can also disseminate to other tissues. We identified a M. tuberculosis (Mtb) outbreak presenting with unusually high rates of extrapulmonary dissemination and bone disease. We ...
Full textLink to itemCite
Journal ArticlemedRxiv · August 16, 2022
BACKGROUND: Results from observational studies and randomized clinical trials (RCTs) have led to the consensus that hydroxychloroquine (HCQ) and chloroquine (CQ) are not effective for COVID-19 prevention or treatment. Pooling individual participant data, i ...
Full textLink to itemCite
Journal ArticleNat Commun · August 8, 2022
Tuberculosis (TB) is a communicable disease caused by Mycobacterium tuberculosis (Mtb) and is a major cause of morbidity and mortality. Successful treatment requires strict adherence to drug regimens for prolonged periods of time. Long-acting (LA) delivery ...
Full textOpen AccessLink to itemCite
Journal ArticleOpen Forum Infect Dis · August 2022
Coinfections are more common in patients with cystic fibrosis and bronchiectasis. Infiltrates on imaging studies are seen more commonly in patients with coinfections, but coinfections did not affect treatment outcomes of pulmonary Mycobacterium avium compl ...
Full textOpen AccessLink to itemCite
Journal ArticleThe Lancet. Infectious diseases · July 2022
The 2020 clinical practice guideline for the treatment of non-tuberculous mycobacterial pulmonary disease (NTM-PD) by the American Thoracic Society, European Respiratory Society, European Society of Clinical Microbiology and Infectious Diseases, and Infect ...
Full textCite
Journal ArticleClin Microbiol Infect · July 2022
OBJECTIVES: Interferon-γ release assays, including T-SPOT.TB (TSPOT) and QuantiFERON Gold In-Tube (QFT), are important diagnostic tools for tuberculosis infection, but little work has been done to study the performance of these tests in populations priorit ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · April 19, 2022
A recent landmark trial showed a 4-month regimen of rifapentine, pyrazinamide, moxifloxacin, and isoniazid (PZMH) to be noninferior to the 6-month standard of care. Here, two murine models of tuberculosis were used to test whether novel regimens replacing ...
Full textLink to itemCite
Journal ArticleSouth Med J · April 2022
OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic has disproportionately afflicted vulnerable populations. Older adults, particularly residents of nursing facilities, represent a small percentage of the population but account for 40% of mortalit ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Clin Microbiol · January 19, 2022
Whole-genome sequencing (WGS) has recently been used to investigate acquisition of Mycobacterium abscessus. Investigators have reached conflicting conclusions about the meaning of genetic distances for interpretation of person-to-person transmission. Exist ...
Full textLink to itemCite
Journal ArticleLancet Infect Dis · January 2022
BACKGROUND: Treatment of latent tuberculosis infection is an important strategy to prevent tuberculosis disease. In the USA, three tests are used to identify latent tuberculosis infection: the tuberculin skin test (TST) and two IFN-γ release assays (T-SPOT ...
Full textLink to itemCite
Journal ArticlePLoS One · 2022
BACKGROUND: Results from observational studies and randomized clinical trials (RCTs) have led to the consensus that hydroxychloroquine (HCQ) and chloroquine (CQ) are not effective for COVID-19 prevention or treatment. Pooling individual participant data, i ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · November 2, 2021
BACKGROUND: Most tuberculosis (TB) disease in the United States (US) is attributed to reactivation of remotely acquired latent TB infection (LTBI) in non-US-born persons who were likely infected with Mycobacterium tuberculosis in their countries of birth. ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · October 5, 2021
BACKGROUND: Increased risk of progression from latent tuberculosis infection (LTBI) to tuberculosis (TB) disease among people living with human immunodeficiency virus (HIV; PLWH) prioritizes them for LTBI testing and treatment. Studies comparing the perfor ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · August 2, 2021
We analyzed the impact of a hospital tap water avoidance protocol on respiratory isolation of nontuberculous mycobacteria (NTM). After protocol implementation, hospital-onset episodes of respiratory NTM isolation on high-risk units decreased from 41.0 to 9 ...
Full textLink to itemCite
Journal ArticleEur Respir J · July 2021
Pyrazinamide is a potent sterilising agent that shortens the treatment duration needed to cure tuberculosis. It is synergistic with novel and existing drugs for tuberculosis. The dose of pyrazinamide that optimises efficacy while remaining safe is uncertai ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · June 15, 2021
BACKGROUND: Nontuberculous mycobacteria (NTM) are a rare cause of infectious tenosynovitis of the upper extremity. Using molecular methods, clinical microbiology laboratories are increasingly reporting identification down to the species level. Improved met ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · May 18, 2021
BACKGROUND: Nontuberculous mycobacteria (NTM) are opportunistically pathogenic bacteria that are found abundantly in the soil and water. Susceptible individuals exposed to NTM-containing aerosols from environmental sources may develop NTM pulmonary disease ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · May 18, 2021
BACKGROUND: Understanding the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for public health control efforts. Social, demographic, and political characteristics at the United States (US) county level might be as ...
Full textOpen AccessLink to itemCite
Journal ArticleNat Commun · April 15, 2021
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or early discontinuation. We aim to estimate the effects of hydroxychloroquine a ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · April 8, 2021
BACKGROUND: We recently mitigated a clonal outbreak of hospital-acquired Mycobacterium abscessus complex (MABC), which included a large cluster of adult patients who developed invasive infection after exposure to heater-cooler units during cardiac surgery. ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · April 8, 2021
BACKGROUND: The increasing global prevalence of pulmonary nontuberculous mycobacteria (NTM) disease has called attention to challenges in NTM diagnosis and management. This study was conducted to understand management and outcomes of patients with pulmonar ...
Full textLink to itemCite
Journal ArticleSci Total Environ · April 1, 2021
The prevalence of pulmonary nontuberculous mycobacteria (NTM) disease is increasing in the United States. Associations were evaluated among residents of central North Carolina between pulmonary isolation of NTM and environmental risk factors including: sur ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · August 14, 2020
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cyst ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · August 14, 2020
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cyst ...
Full textLink to itemCite
Journal ArticleEur Respir J · July 2020
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cyst ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · March 1, 2020
Rationale: Noninferiority trials of treatment for latent tuberculosis infection (LTBI) are challenging because of imperfect LTBI diagnostic tests.Objectives: To assess the effect on study outcomes of different enrollment strategies for a noninferiority tri ...
Full textLink to itemCite
Journal Article · 2020
Background Understanding the epidemiology of SARS-CoV-2 is essential for public health control efforts. Social, demographic, and political characteristics at the US county level might be associated with the trajectories of SARS-CoV-2 case incidenc ...
Full textCite
Journal ArticlePLoS One · 2020
BACKGROUND: Novel approaches are required to better focus latent tuberculosis infection (LTBI) efforts in low-prevalence regions. Geographic information systems, used within large health systems, may provide one such approach. METHODS: A retrospective, cro ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Clin Tuberc Other Mycobact Dis · December 2019
The American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) have provided guidelines to assist in the accurate diagnosis of lung disease caused by nontuberculous mycobacteria (NTM). These microbiologic, radiographic, and clinical ...
Full textOpen AccessLink to itemCite
Journal ArticleAnnu Rev Med · January 27, 2019
Resistance to antimycobacterial drugs is a major barrier to effective treatment of Mycobacterium tuberculosis infection. Molecular diagnostic techniques based on the association between specific gene mutations and phenotypic resistance to certain drugs off ...
Full textLink to itemCite
Journal ArticleThorax · November 2018
BACKGROUND: Lack of a gold standard for latent TB infection has precluded direct measurement of test characteristics of the tuberculin skin test and interferon-γ release assays (QuantiFERON Gold In-Tube and T-SPOT.TB). OBJECTIVE: We estimated test sensitiv ...
Full textLink to itemCite
Journal ArticlePostgrad Med J · September 2018
PURPOSE: As tuberculosis becomes less common in higher income countries, clinician familiarity with the disease is declining. Little is known about how chest radiograph interpretations affect tuberculosis care. We sought to determine how tuberculosis-relat ...
Full textLink to itemCite
Journal ArticleTranspl Infect Dis · August 2018
BACKGROUND: Nocardia are uncommon pathogens that disproportionately afflict the immunocompromised host. Epidemiology and outcome data of Nocardia infections in transplant recipients are limited. METHODS: We performed a retrospective chart review of all pat ...
Full textLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · May 1, 2018
SETTING: Serial screening for latent tuberculous infection (LTBI) is commonly performed in certain populations, such as health care workers. The high apparent conversion rate in some studies of interferon-gamma release assays is puzzling given the claimed ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · May 2018
BACKGROUND: The traditional definition of engagement in HIV care in terms of only clinic attendance and viral suppression provides a limited understanding of how persons living with HIV (PLWH) interact with the health care system. METHODS: We conducted a r ...
Full textOpen AccessLink to itemCite
Journal ArticleGenome Announc · February 15, 2018
Whole-genome sequencing has resulted in new insights into the phylogeography of Mycobacterium tuberculosis However, only limited genomic data are available from M. tuberculosis strains in Guatemala. Here we report 16 complete genomes of clinical strains be ...
Full textOpen AccessLink to itemCite
Journal ArticleAIDS Educ Prev · August 2017
Patients admitted with pneumonia are at higher risk for HIV and should be routinely screened. We examined a retrospective cohort of patients admitted to Duke University Health System with a primary diagnosis of pneumonia. During the study period, 6,951 per ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · April 1, 2017
BACKGROUND: Nontuberculous mycobacteria (NTM) commonly colonize municipal water supplies and cause healthcare-associated outbreaks. We investigated a biphasic outbreak of Mycobacterium abscessus at a tertiary care hospital. METHODS: Case patients had recen ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · March 1, 2017
Pathogenic mycobacteria trigger formation of organized granulomas. As granulomas mature, they induce angiogenesis and vascular permeability. Here, in a striking parallel to tumor pro-angiogenic signaling, we identify angiopoietin-2 (ANG-2) induction as an ...
Full textLink to itemCite
Journal ArticleAnn Am Thorac Soc · March 2017
RATIONALE: Nocardia is a genus of pathogens that most commonly afflict immunocompromised hosts but may be an emerging infection among persons with bronchiectasis. OBJECTIVES: To examine the epidemiology and clinical presentation of adult patients with Noca ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · 2017
BACKGROUND: Despite the advent of combination antiretroviral therapy (cART), patients with human immunodeficiency virus (HIV) continue to develop late-stage complications including acquired immune deficiency syndrome (AIDS), disseminated Mycobacterium aviu ...
Full textOpen AccessLink to itemCite
Journal ArticleImmunity · October 18, 2016
Mycobacterium tuberculosis infection in humans triggers formation of granulomas, which are tightly organized immune cell aggregates that are the central structure of tuberculosis. Infected and uninfected macrophages interdigitate, assuming an altered, flat ...
Full textLink to itemCite
Journal ArticleJ Dermatolog Treat · August 2016
Systemic biologic therapy has become commonplace for the treatment of a variety of inflammatory dermatologic conditions, particularly psoriasis. Screening for latent tuberculosis infection (LTBI) is recommended prior to initiation of systemic biologic agen ...
Full textLink to itemCite
Journal ArticleJ Infect · June 2016
BACKGROUND: Nontuberculous mycobacteria (NTM) are environmental mycobacteria associated with a range of infections. Reports of NTM epidemiology have primarily focused on pulmonary infections and isolations, however extrapulmonary infections of the skin, so ...
Full textLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · June 2016
BACKGROUND: Shorter treatment regimens for tuberculosis (TB) are deemed vital for advancing TB control. Murine studies have suggested potential new regimens; however, Phase II human studies of these drug combinations have not shown clear improvement in 2-m ...
Full textLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · May 2016
SETTING: Two-month solid medium culture conversion is a commonly used, if suboptimal, endpoint for phase 2 anti-tuberculosis treatment trials. OBJECTIVE AND DESIGN: To model the effect of the performance characteristics (sensitivity and contamination rate) ...
Full textLink to itemCite
Journal ArticleInt J Infect Dis · April 2016
Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of chronic pulmonary infection, posing a number of challenges for both clinicians and researchers. While a number of studies worldwide have described an increasing prevalence o ...
Full textLink to itemCite
Journal ArticleTex Heart Inst J · April 2016
A 69-year-old man presented with a progressively enlarging pulsatile mass in the left side of his chest. Because of a history of an ischemic cardiomyopathy, he had been randomized in 2003 to undergo coronary artery bypass grafting with a Dor procedure, as ...
Full textLink to itemCite
Journal ArticleBMC Med · March 23, 2016
BACKGROUND: The standard 6-month four-drug regimen for the treatment of drug-sensitive tuberculosis has remained unchanged for decades and is inadequate to control the epidemic. Shorter, simpler regimens are urgently needed to defeat what is now the world' ...
Full textOpen AccessLink to itemCite
Journal ArticleN C Med J · 2016
BACKGROUND: Effective investigation of tuberculosis (TB) contacts is essential for continued progress toward TB elimination. As the incidence of TB declines, staff experience will also decline. Little is known about the association between the experience l ...
Full textLink to itemCite
Journal ArticleInfection · December 2015
PURPOSE: Invasive Mycobacterium marinum disease (tenosynovitis and osteomyelitis) may be an increasingly common manifestation of M. marinum infection that presents unique diagnostic and therapeutic challenges. We conducted a retrospective case series and l ...
Full textLink to itemCite
Journal ArticleTuberculosis (Edinb) · December 2015
Limited data are available regarding the molecular epidemiology of Mycobacterium tuberculosis (Mtb) strains circulating in Guatemala. Beijing-lineage Mtb strains have gained prevalence worldwide and are associated with increased virulence and drug resistan ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · March 2015
The Xpert(®) MTB/RIF assay has demonstrated robust capability for diagnosing tuberculosis (TB) and rifampin (RMP) resistance. Optimal use of Xpert in diverse settings will require knowledge of challenges when interpreting the results. We present three sele ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · February 1, 2015
RATIONALE: Rifapentine has potent activity in mouse models of tuberculosis chemotherapy but its optimal dose and exposure in humans are unknown. OBJECTIVES: We conducted a randomized, partially blinded dose-ranging study to determine tolerability, safety, ...
Full textLink to itemCite
Journal ArticleN C Med J · 2015
BACKGROUND: The HIV/AIDS epidemic is a significant public health concern in North Carolina, and previous research has pointed to elevated mental health distress and substance use among HIV-infected populations, which may impact patients' adherence to medic ...
Full textOpen AccessLink to itemCite
Journal ArticleTranspl Infect Dis · October 2014
Hepatitis B virus (HBV) core antibody (HBcAb)-positive donors are increasingly utilized in solid organ transplantation. We report a single center's experience in cardiac transplantation with 18 HBcAb-positive donors. Available follow-up on recipients of ca ...
Full textLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · October 2014
Mycobacterium abscessus complex is a group of rapidly growing mycobacteria, and an emerging cause of non-tuberculous mycobacterial lung disease in patients with cystic fibrosis and chronic lung diseases, such as bronchiectasis. M. abscessus complex is the ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · September 2014
BACKGROUND: We sought to characterize the clinical utility of indium 111 ((111)In)-labeled white blood cell (WBC) scans by indication, to identify patient populations who might benefit most from this imaging modality. METHODS: Medical records for all patie ...
Full textOpen AccessLink to itemCite
Journal ArticlePLoS ONE · June 11, 2014
Background: Vaccine-induced human antibodies to surface components of Haemophilus influenzae and Streptococcus pneumonia are correlated with protection. Monoclonal antibodies to surface components of Mycobacterium tuberculosis are also protective in animal ...
Full textCite
Journal ArticleBMC Infect Dis · February 20, 2014
BACKGROUND: Routine tuberculosis culture remains unavailable in many high-burden areas, including Tanzania. This study sought to determine the impact of providing mycobacterial culture results over standard of care [unconcentrated acid-fast (AFB) smears] o ...
Full textOpen AccessLink to itemCite
Journal ArticleBMC Infectious Diseases · February 20, 2014
Background: Routine tuberculosis culture remains unavailable in many high-burden areas, including Tanzania. This study sought to determine the impact of providing mycobacterial culture results over standard of care [unconcentrated acid-fast (AFB) smears] o ...
Full textCite
Journal ArticleBMC Infect Dis · February 10, 2014
BACKGROUND: In an attempt to curtail the rising morbidity and mortality from undiagnosed HCV (hepatitis C virus) in the United States, screening guidelines have been expanded to high-risk individuals and persons born 1945-1965. Community-based screening ma ...
Full textOpen AccessLink to itemCite
Journal ArticlePublic Health Rep · 2014
Combating the syndemics of tuberculosis (TB) and HIV in the United States will require increasing efficiency as the incidence of TB declines. Fortunately, new tools such as the interferon gamma release assays can be combined with existing strategies such a ...
Full textLink to itemCite
Journal ArticlePLoS One · 2014
BACKGROUND: Vaccine-induced human antibodies to surface components of Haemophilus influenzae and Streptococcus pneumonia are correlated with protection. Monoclonal antibodies to surface components of Mycobacterium tuberculosis are also protective in animal ...
Full textOpen AccessLink to itemCite
Journal ArticleTelemed J E Health · January 2014
INTRODUCTION: Failure to attend medical appointments among persons living with human immunodeficiency virus (HIV) has been associated with poor health outcomes. Text message appointment reminders are a novel tool to potentially improve appointment attendan ...
Full textLink to itemCite
Journal ArticleSex Transm Dis · November 2013
The impact of syphilis reverse sequence screening has not been evaluated in community outreach. Using reverse sequence screening in neighborhoods identified with geographic information systems, we found that among 239 participants, 45 (19%) were seropositi ...
Full textLink to itemCite
Journal ArticleJ Clin Microbiol · October 2013
Amikacin is a major drug used for the treatment of Mycobacterium avium complex (MAC) disease, but standard laboratory guidelines for susceptibility testing are not available. This study presents in vitro amikacin MICs for 462 consecutive clinical isolates ...
Full textLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · June 2013
SETTING: As the incidence of tuberculosis (TB) declines in high-income countries, resources to control TB are also declining. A portion of these resources are utilized for the evaluation and treatment of persons initially suspected of, but who do not actua ...
Full textLink to itemCite
Journal ArticleEmerg Infect Dis · March 2013
Nontuberculous mycobacteria are increasingly associated with cutaneous infections after cosmetic procedures. Fractionated CO2 resurfacing, a widely used technique for photorejuvenation, has been associated with a more favorable side effect profile than alt ...
Full textOpen AccessLink to itemCite
Journal ArticleN C Med J · 2013
Successful collaborations between academic researchers and local health departments are vital for public health research, but developing and maintaining such partnerships is often difficult. However, in the North Carolina Tuberculosis Control Program, such ...
Link to itemCite
Journal ArticleN C Med J · 2013
Tuberculosis is a major cause of morbidity and mortality worldwide, but the number of cases is now lower than ever before, both in the United States and in North Carolina. Although case rates are declining, public health funding for tuberculosis is also de ...
Link to itemCite
Journal ArticleJ Infect Dis · October 1, 2012
BACKGROUND: Rifapentine administered 5 days per week has potent activity in mouse models of antituberculosis chemotherapy, but efficacy and safety data are limited in humans. We compared the antimicrobial activity and safety of rifapentine vs rifampin duri ...
Full textLink to itemCite
Journal ArticleBMC Public Health · June 21, 2012
Featured Publication
BACKGROUND: Treatment of latent tuberculosis infection (LTBI) is a key component in U.S. tuberculosis control, assisted by recent improvements in LTBI diagnostics and therapeutic regimens. Effectiveness of LTBI therapy, however, is limited by patients' wil ...
Full textOpen AccessLink to itemCite
Journal ArticlePLoS One · 2012
Featured Publication
BACKGROUND: The optimal treatment for latent multiple-drug resistant tuberculosis infection remains unclear. In anticipation of future clinical trials, we modeled the expected performance of six potential regimens for treatment of latent multiple-drug resi ...
Full textOpen AccessLink to itemCite
Journal ArticlePLoS One · 2012
Featured Publication
OBJECTIVE: To determine the feasibility and case detection rate of a geographic information systems (GIS)-based integrated community screening strategy for tuberculosis, syphilis, and human immunodeficiency virus (HIV). DESIGN: Prospective cross-sectional ...
Full textOpen AccessLink to itemCite
Journal ArticleBMC Infect Dis · November 2, 2011
Featured Publication
BACKGROUND: Community-based screening for TB, combined with HIV and syphilis testing, faces a number of barriers. One significant barrier is the value that target communities place on such screening. METHODS: Integrated testing for TB, HIV, and syphilis wa ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · November 2011
SETTING: Pulmonary tuberculosis (TB) patients reported in North Carolina (NC), USA, from 1996 to 2008 (inclusive). OBJECTIVE: To compare prevalence of cavitary TB as a surrogate marker for advanced disease in low-caseload counties with high-caseload counti ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · October 2011
Featured Publication
BACKGROUND: Pedicure-associated nontuberculous mycobacterial furunculosis has been reported in the setting of either outbreaks or sporadic case reports. The epidemiology of these infections is not well understood. METHODS: Systematic surveillance for pedic ...
Full textLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · May 2011
Featured Publication
In 2009, the United States experienced a record drop in its tuberculosis (TB) case rate, coinciding with a major economic downturn. To investigate this relationship, we modeled short-term changes in gross domestic product, unemployment, and immigration as ...
Full textLink to itemCite
Journal ArticleTuberculosis (Edinb) · May 2011
Featured Publication
We sought to identify biomarker responses to tuberculosis specific antigens which could 1) improve the diagnosis of tuberculosis infection and 2) allow the differentiation of active and latent infections. Seventy subjects with active tuberculosis (N = 12), ...
Full textLink to itemCite
Journal ArticleTelemed J E Health · April 2011
Featured Publication
OBJECTIVES: The objective of this study was to assess knowledge, attitudes, and behaviors surrounding healthcare-related mobile phone use and text messaging among persons at risk for or infected with tuberculosis (TB) or the human immunodeficiency virus (H ...
Full textLink to itemCite
Journal ArticleTelemedicine journal and e-health : the official journal of the American Telemedicine Association · April 1, 2011
The objective of this study was to assess knowledge, attitudes, and behaviors surrounding healthcare-related mobile phone use and text messaging among persons at risk for or infected with tuberculosis (TB) or the human immunodeficiency virus (HIV). An anon ...
Cite
Journal ArticleInt J Tuberc Lung Dis · February 2011
Featured Publication
SETTING: North Carolina, United States. OBJECTIVE: To investigate the demographic and behavioral risk factors associated with death among tuberculosis (TB) patients in North Carolina. DESIGN: Retrospective cohort of all TB patients reported in North Caroli ...
Link to itemCite
Journal ArticlePLoS One · 2011
Featured Publication
RATIONALE: Rifapentine-based regimens for treating latent tuberculosis infection (LTBI) are being considered for future clinical trials, but even if they prove effective, high drug costs may limit their economic viability. OBJECTIVES: To inform clinical tr ...
Full textOpen AccessLink to itemCite
Journal ArticleAIDS Patient Care STDS · September 2010
Featured Publication
Knowing one's HIV status is particularly important in the setting of recent tuberculosis (TB) exposure. Blood tests for assessment of tuberculosis infection, such as the QuantiFERON Gold in-tube test (QFT; Cellestis Limited, Carnegie, Victoria, Australia), ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Med Microbiol · July 2010
Featured Publication
Infections due to Aspergillus species cause significant morbidity and mortality. Most are attributed to Aspergillus fumigatus, followed by Aspergillus flavus and Aspergillus terreus. Aspergillus niger is a mould that is rarely reported as a cause of pneumo ...
Full textOpen AccessLink to itemCite
Journal ArticlePLoS One · May 20, 2010
Featured Publication
Recent studies suggest that M. tuberculosis lineage and host genetics interact to impact how active tuberculosis presents clinically. We determined the phylogenetic lineages of M. tuberculosis isolates from participants enrolled in the Tuberculosis Trials ...
Full textOpen AccessLink to itemCite
Journal ArticleAcad Radiol · February 2010
Featured Publication
RATIONALE AND OBJECTIVES: Chest radiographic findings are important for diagnosis and management of tuberculosis. The reliability of these findings is therefore of interest. We sought to describe interobserver reliability of chest radiographic findings in ...
Full textLink to itemCite
Journal ArticlePLoS ONE · 2010
Recent studies suggest that M. tuberculosis lineage and host genetics interact to impact how active tuberculosis presents clinically. We determined the phylogenetic lineages of M. tuberculosis isolates from participants enrolled in the Tuberculosis Trials ...
Full textCite
Journal ArticleAIDS Patient Care STDS · October 2009
Featured Publication
Persons coinfected with tuberculosis (TB) and HIV are at high risk of death, in part due to suboptimal utilization of HIV-specific health care. We sought to better understand HIV-associated health care utilization and mortality in a retrospective cohort of ...
Full textLink to itemCite
Journal ArticleAm J Trop Med Hyg · August 2009
Featured Publication
Chronic helminth infections are common in refugee populations and may persist years after immigration. Asymptomatic Strongyloides stercoralis infection raises particular concern because of its potential for complications in immunosuppressed patients. We ex ...
Link to itemCite
Journal ArticleAm J Respir Crit Care Med · August 1, 2009
RATIONALE: Moxifloxacin has potent activity against Mycobacterium tuberculosis in vitro and in a mouse model of antituberculosis (TB) chemotherapy, but data regarding its activity in humans are limited. OBJECTIVES: Our objective was to compare the antimicr ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · June 1, 2009
Featured Publication
RATIONALE: Isoniazid given daily for 9 months is the standard treatment for latent tuberculosis infection (LTBI), but its effectiveness is limited by poor completion rates. Shorter course regimens and regimens using directly observed therapy result in impr ...
Full textLink to itemCite
Journal ArticlePharmacotherapy · May 2009
Featured Publication
STUDY OBJECTIVE: To determine the feasibility of therapeutic drug monitoring for adjusting low serum antimycobacterial concentrations in patients with both tuberculosis and advanced human immunodeficiency virus (HIV). DESIGN: Retrospective cohort study. DA ...
Full textLink to itemCite
Journal ArticleJ Infect · May 2009
Featured Publication
OBJECTIVES: Excess alcohol use represents a significant challenge in tuberculosis control. Whether alcohol use enhances transmission of Mycobacterium tuberculosis is not known. METHODS: We analyzed North Carolina, USA surveillance data for all adult (>14 y ...
Full textLink to itemCite
Journal ArticleAm J Infect Control · March 2009
Featured Publication
BACKGROUND: This study examined predictors of in-hospital mortality and time to extubation among patients with acute, severe hospital-acquired pneumonia (HAP) managed in the intensive care unit (ICU). METHODS: Patients with HAP prospectively identified bet ...
Full textLink to itemCite
Journal ArticleJ Infect · November 2008
Featured Publication
OBJECTIVES: Excess alcohol use represents a significant challenge in tuberculosis control. Whether alcohol use enhances transmission of Mycobacterium tuberculosis is not known. METHODS: We analyzed North Carolina, USA surveillance data for all adult (> 14 ...
Full textLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · September 2008
Featured Publication
SETTING: Patients with cavitary pulmonary tuberculosis (TB) on baseline chest radiograph (CXR) who remain culture-positive after 8 weeks of treatment are at high risk of relapse. The role of end-of-treatment (EOT) CXR in predicting relapse is unclear. OBJE ...
Link to itemCite
Journal ArticleJ Clin Microbiol · August 2008
Featured Publication
Organisms within the Mycobacterium avium complex (MAC) may have differential virulence. We compared 33 subjects with MAC pulmonary disease to 75 subjects with a single positive culture without disease. M. avium isolates were significantly more likely to be ...
Full textLink to itemCite
Journal ArticleBMC Public Health · April 4, 2008
Featured Publication
BACKGROUND: The proportion of extrapulmonary tuberculosis (EPTB) reported in the United States has been gradually increasing. HIV infection and foreign birth are increasingly associated with tuberculosis and understanding their effect on the clinical prese ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Microbiol Rev · April 2008
Featured Publication
A pulmonary cavity is a gas-filled area of the lung in the center of a nodule or area of consolidation and may be clinically observed by use of plain chest radiography or computed tomography. Cavities are present in a wide variety of infectious and noninfe ...
Full textLink to itemCite
Journal ArticleN C Med J · 2008
Featured Publication
OBJECTIVE: The purpose of this study was to capture and describe knowledge, attitudes, and beliefs about tuberculosis (TB) among persons at high risk for TB infection. METHODS: We conducted 11 focus groups in 3 different populations at high risk for TB inf ...
Link to itemCite
Journal ArticleClin Infect Dis · August 1, 2007
Tuberculosis (TB) is an enormous global public health problem. Cases of extensively drug-resistant TB (XDR-TB) are being reported in increasing numbers across the globe. A large outbreak of XDR-TB associated with rapid and nearly universal mortality has be ...
Full textLink to itemCite
Journal ArticleExpert Rev Anti Infect Ther · December 2006
Featured Publication
Nontuberculous mycobacteria (NTM) are emerging pathogens increasingly associated with chronic pulmonary disease. NTM are environmental saprophytes found in soil, dust and water and, unlike Mycobacterium tuberculosis, NTM are not transmitted from person to ...
Full textLink to itemCite
Journal ArticleInfections in Medicine · September 1, 2006
Patients with pulmonary disease caused by nontuberculous mycobacteria typically present with chronic cough and fatigue, sometimes with hemoptysis and weight loss as well. High-resolution CT is the most helpful radiographic study; it typically shows pulmona ...
Cite
Journal ArticleInt J Tuberc Lung Dis · July 2006
Featured Publication
SETTING: North Carolina, USA. OBJECTIVE: To understand physicians' knowledge and attitudes toward the treatment of young children with latent tuberculosis infection (LTBI) in a low-incidence region. DESIGN: Cross-sectional survey of 525 pediatricians and 5 ...
Link to itemCite
Journal ArticleArch Pediatr Adolesc Med · June 2006
Featured Publication
OBJECTIVES: To investigate an increase in active pediatric tuberculosis (TB) cases in North Carolina from 9 cases in 2001 to 32 cases in 2002, and to pilot test a screening tool for detection of latent TB infection in children. DESIGN: Retrospective cohort ...
Full textLink to itemCite
Journal ArticleJ Aerosol Med · 2006
The treatment of pulmonary infectious diseases with pharmaceutical aerosols is an attractive option considering the accessibility of the lungs for topical drug delivery. Aerosols have been targeted to the lungs for the treatment of asthma with great succes ...
Full textLink to itemCite
Journal ArticleInt J Infect Dis · November 2005
Featured Publication
Despite attempts to standardize tuberculosis (TB) control strategies, there remains wide variation in the selection and implementation of control strategies within and among nations. Some of this variation is appropriate; based on wide variations in the av ...
Full textLink to itemCite
Journal ArticleArch Intern Med · February 14, 2005
Featured Publication
BACKGROUND: Infections occurring among outpatients having recent contact with the health care system have been termed health care-associated infections. The objective of this study was to analyze the impact of health care-associated status on effectiveness ...
Full textLink to itemCite
Journal ArticleExpert Rev Anticancer Ther · December 2004
Despite recent advances in both technology and molecular targeting, little progress has been made in the management of most malignancies of the brain, especially brain metastases. In an effort to increase the therapeutic ratio of external beam radiation tr ...
Full textLink to itemCite
Journal ArticleExpert Opin Drug Saf · May 2004
Featured Publication
A 2-month regimen of rifampin and pyrazinamide (2RZ) became an accepted alternative for treatment of latent tuberculosis (TB) after initial studies in HIV-seropositive patients demonstrated safety and efficacy. Once this alternative came into widespread us ...
Full textLink to itemCite
Journal ArticleInfection · April 2004
Featured Publication
BACKGROUND: Based on previous studies, enterococcal infective endocarditis (IE) is considered a unimicrobial, community-acquired disease of older Caucasian men. PATIENTS AND METHODS: We evaluated the relationship between enterococcal bacteremia and IE by c ...
Full textLink to itemCite
Journal ArticleAm J Respir Crit Care Med · March 15, 2003
Featured Publication
An alternative regimen for the treatment of latent tuberculosis infection is 2 months of rifampin and pyrazinamide, but some patients have died of hepatitis associated with this therapy. One hundred fourteen patients received rifampin/pyrazinamide in Wake ...
Full textLink to itemCite
Journal ArticleAnn Intern Med · November 19, 2002
Featured Publication
BACKGROUND: Bloodstream infections occurring in persons residing in the community, regardless of whether those persons have been receiving health care in an outpatient facility, have traditionally been categorized as community-acquired infections. OBJECTIV ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · August 15, 2002
Featured Publication
We report a case of retinal toxoplasmosis that occurred in a patient with acquired immunodeficiency syndrome who had a previous diagnosis of cerebral toxoplasmosis, despite the patient having had a robust immune response to highly active antiretroviral the ...
Full textLink to itemCite
Journal ArticleSouth Med J · February 2002
Featured Publication
BACKGROUND: Human immunodeficiency virus (HIV) testing is recommended for all patients with tuberculosis (TB). METHODS: Surveillance data for all reported cases of TB in North Carolina from 1993 to 1999 were examined to assess HIV testing practices. RESULT ...
Link to itemCite
Journal ArticleInfect Control Hosp Epidemiol · November 2001
Featured Publication
We prospectively assessed the management of patients with suspected tuberculosis (TB) in an area with a high prevalence of nontuberculous mycobacteria (NTM) and a low incidence of TB. Clinicians' assessments were sensitive for TB but had poor predictive va ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · August 15, 2001
Featured Publication
We describe a 27-year-old woman with peritonitis due to Mycobacterium bovis that initially appeared to be ovarian cancer. Clinicians should include this disease in the differential diagnosis of ovarian cancer and should consider laparoscopic diagnosis in t ...
Full textLink to itemCite